Network Firm News
AKERMAN SENTERFITT POST-TRIAL MOTIONS PREVAIL IN ARRIVA V. ALPHAMED
Judge rules in Arriva's favor, dismissing jury's $78 million recommendation for damages
Akerman Senterfitt announced today that on Friday, May 26, U.S. District Judge Cecilia Altonaga handed down a 60-page order in favor of the firm's client, Arriva Pharmaceuticals Inc., after three months of post-trial motions. Alphamed Pharmaceuticals Corp. had brought the case to trial in September 2005, alleging that Arriva and an Arizona private investigation firm stole its trade secrets and tried to destroy its business. Friday's ruling dismissed a jury recommendation presented in January of this year of $78 million in damages, resulting in the best possible outcome for Arriva. The judge also dismissed the $1.00 in nominal damages which AlphaMed had previously obtained on the misappropriation of trade secrets count.
Akerman Senterfitt litigation attorney Jonathan Goodman, the lead attorney for Arriva at both the trial and the post-trial motions, had convinced the Judge not to enter judgment based on the jury's recommendation until ruling on post-trial motions. Goodman was successful in presenting briefings that resulted in the Judge dismissing the case on the merits.
"I couldn't be more pleased for our client," said Goodman. "It's always a challenge to prevail on post-trial motions such as these, but we were confident that the Judge would agree with our position."